FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

7142211000001109: Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20276301000001110 Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
59577901000001110 Conjugated oestrogens 1.25mg tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Is a Product containing precisely conjugated estrogen 1.25 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has active ingredient Conjugated estrogen false Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has specific active ingredient Conjugated estrogen true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) 84 tablet Is pack of False Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) 84 tablet Has AMP True Conjugated oestrogens 1.25mg tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start